Nexa3D, a leading US manufacturer of high-performance 3D printers for industrial applications, and Addifab, a 3D printed tooling pioneer, announce that they are joining forces to bring a novel 3D printed injection mold tooling platform to injection molders globally.

The platform, Freeform Injection Molding (FIM), offers a value proposition: Based on 3D printing technology, the FIM process allows the user to additively manufacture complex injection mold tooling in hours instead of weeks or months.

Nexa3D and Addifab are bringing a novel 3D printed injection mold tooling platform to injection molders.

These tools are compatible with most thermoplastic materials, including reinforced high-performance feedstocks. They can also be dissolved, which allows the molding of complex components that would otherwise be difficult – or even impossible – to mold with conventional metal tooling.

“Injection molding is a complex process, and the tool building is the most complex part of the process,” told Lasse Staal, co-founding CEO of Addifab. “With Freeform Injection Molding, we provide injection molders with a fully transparent set of tools (no pun intended) that will allow them to fast-track tool designs and validations while raising the bar on tool innovation. Now we can take these capabilities to the next level by partnering with Nexa3D to broaden access and superpower performance.”

For the new platform, Nexa3D will supply their NXE 400 system, while Addifab will supply their proprietary tooling resins and post-processing equipment.

Through this collaboration, Nexa3D will supply their NXE 400 system, including the industrial 3D printer as well as wash and cure units, to users of Freeform Injection Molding, while Addifab will be supplying their proprietary tooling resins and post-processing equipment.

“I had the opportunity to witness the powerful impact of Freeform Injection Molding (FIM) for the first time at the RAPID + TCT conference in 2019, and was instinctively intrigued by its potential to reimagine additive tooling,” stated Avi Reichental, Co-Founder, Chairman, and CEO of Nexa3D. “As both Addifab and Nexa3D have since productized and industrialized our respective processes, it became obvious that together, we can achieve much more by digitizing injection molding at convincing scale sustainably.”

Coming full circle, Nexa3D and Addifab will showcase their joint solution at the RAPID + TCT show in Detroit. The companies are also setting up joint Silicon Valley demo facilities in Palo Alto, CA.

Nexa3D, a leading US manufacturer of high-performance 3D printers for industrial applications, and Addifab, a 3D printed tooling pioneer, announce that they are joining forces to bring a novel 3D printed injection mold tooling platform to injection molders globally.

The platform, Freeform Injection Molding (FIM), offers a value proposition: Based on 3D printing technology, the FIM process allows the user to additively manufacture complex injection mold tooling in hours instead of weeks or months.

Nexa3D and Addifab are bringing a novel 3D printed injection mold tooling platform to injection molders.

These tools are compatible with most thermoplastic materials, including reinforced high-performance feedstocks. They can also be dissolved, which allows the molding of complex components that would otherwise be difficult – or even impossible – to mold with conventional metal tooling.

“Injection molding is a complex process, and the tool building is the most complex part of the process,” told Lasse Staal, co-founding CEO of Addifab. “With Freeform Injection Molding, we provide injection molders with a fully transparent set of tools (no pun intended) that will allow them to fast-track tool designs and validations while raising the bar on tool innovation. Now we can take these capabilities to the next level by partnering with Nexa3D to broaden access and superpower performance.”

For the new platform, Nexa3D will supply their NXE 400 system, while Addifab will supply their proprietary tooling resins and post-processing equipment.

Through this collaboration, Nexa3D will supply their NXE 400 system, including the industrial 3D printer as well as wash and cure units, to users of Freeform Injection Molding, while Addifab will be supplying their proprietary tooling resins and post-processing equipment.

“I had the opportunity to witness the powerful impact of Freeform Injection Molding (FIM) for the first time at the RAPID + TCT conference in 2019, and was instinctively intrigued by its potential to reimagine additive tooling,” stated Avi Reichental, Co-Founder, Chairman, and CEO of Nexa3D. “As both Addifab and Nexa3D have since productized and industrialized our respective processes, it became obvious that together, we can achieve much more by digitizing injection molding at convincing scale sustainably.”

Coming full circle, Nexa3D and Addifab will showcase their joint solution at the RAPID + TCT show in Detroit. The companies are also setting up joint Silicon Valley demo facilities in Palo Alto, CA.